Reported May 7, 2025 · Ongoing
Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles, Manufactured by: Glenmark Pharmaceuticals Limited,…
Preferred Pharmaceuticals, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Preferred Pharmaceuticals, Inc. · 1250 N Lakeview Ave Ste O · Anaheim, CA · 92807-1801
Is this the product you have?
- Clindamycin Hydrochloride Capsules, USP, 300mg, 30-count bottles
- Manufactured byGlenmark Pharmaceuticals Limited, NDC 68788-8685-03
- Lot codes and dates
Lot #: L0224TK1824MK0124NJ1624VJ0824OI2424EI1024OA0925FL2324L
- Exp7/31/2026
- Amount recalled
- 1190 Bottles
Where it was sold
- Nationwide
Why it was recalled
cGMP Deviations
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Preferred Pharmaceuticals, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.